Impact of colchicine on mortality and morbidity in COVID-19: a systematic review

Introduction Colchicine, because of its anti-inflammatory and possible anti-viral properties, has been proposed as potential therapeutic option for COVID-19. The role of colchicine to mitigate “cytokine storm” and to decrease the severity and mortality associated with COVID-19 has been evaluated in...

詳細記述

書誌詳細

出版年:	Annals of Medicine
主要な著者:	Devang Sanghavi, Pankaj Bansal, Ikwinder Preet Kaur, Mohsin Sheraz Mughal, Chandana Keshavamurthy, Austin Cusick, Jennifer Schram, Siva Naga S. Yarrarapu, Abhishek R. Giri, Nirmaljot Kaur, Pablo Moreno Franco, Andy Abril, Fawad Aslam
フォーマット:	論文
言語:	英語
出版事項:	Taylor & Francis Group 2022-12-01
主題:	Colchicine COVID-19 Coronavirus
オンライン･アクセス:	https://www.tandfonline.com/doi/10.1080/07853890.2021.1993327